{"success":true,"data":{"_id":261299868,"filings":[{"Organization":{"Hours":[0],"Total Compensation":[0],"Direct compensation":[0],"Other compensation":[0]},"Basic":{"mission":"Conduct research, development and implementation of technologies for the early detection and monitoring of treatment interventions for blinding retinal eye diseases, cancers and neurodegenerative diseases.","primary_activities":"Donations will be used to conduct research, development and implementation of technologies for the early detection and monitoring of treatment interventions for blinding retinal eye diseases, cancers and neurodegenerative diseases, by non-invasive methodoligies, as well as minimally invasive technologies for early cancer detection and monitoring of effects of chemotherapy. The charitable fund will also make grants to partially fund clinical trials by other research and educational institutions.","year":2010,"name":"JULIUS AND SARA ZUCKERMAN","phone":"2152381510","type":"990","principal_officer":"RALPH ZUCKERMAN PHD","year_formation":2007,"state_legal_domicile":"PA","total_volunteers":2,"tax_period_begin":"2010-01-01T00:00:00","tax_period_end":"2010-12-31T00:00:00","address":"325 CHESTNUT STREET SUITE 610, PHILADELPHIA, PA, 19106, USA","city":"PHILADELPHIA","state":"PA","country":"USA","zip_code":"19106"},"Governance":{"501c3 determination":true,"Number of voting members":2,"Number of independent voting members":1,"Number of employees total":0,"Total Gross UBI":0,"Number of employees":0,"Prohibited tax shelter transactions":false,"Taxable party notification":false,"Funds to pay premiums":false,"Premiums Paid":false,"Family or business relationship":false,"Delegation of management duties":false,"Conflict of interest policy":true,"Whistle blower policy":true,"Compensation process for CEO":false,"Compensation process for other employees":false,"Changes to organizing documents":false,"Material diversion or misuse":false,"Members or stockholders":false,"Election of board members":false,"Decisions subject to approval":false,"Minutes of governing body":true,"Local chapters":false,"Form 990 provided to governing body":true,"Document retention policy":true,"Investment in joint venture":false,"Independent audit financial statements":false,"Consolidated audit financial statements":false,"Accountant compile or review":false,"Financial statements audited by independent accountant":false,"Political activities":false,"Donor advised funds":false,"Conservation easements":false,"Collections of art":false,"School":false,"Hospital":false,"Foreign activities":false,"Foreign office":false,"Gaming":false,"Fundraising activities":false,"Professional fundraising":false,"Loan to officer or DQP":false,"Grant to related person":false,"Business relationship through family member":false,"Business relationship with organization":false,"Transfers to exempt non-charitable organization":false},"Revenues":{"value":50000,"Contributions":{"value":50000,"Other contributions":50000},"Program revenue":{"value":0},"Investment income":{"value":0},"Other revenues":{"value":0}},"Expenses":{"value":13035,"Grant expense":{"value":0},"Total professional fundraising expense":{"value":0},"Benefits paid to members":{"value":0},"Salaries":{"value":0},"Other expenses":{"value":13035,"Accounting":2420,"Occupancy":9400,"Insurance":750,"Itemized Expenses":{"value":465,"VARIOUS":465}}},"Assets":{"value":84961,"Non-interest bearing cash":84961},"Liabilities":{"value":0},"Fund balance":{"value":84961},"Form990Details":{"program_service_accomplishments":[{"description":"DONATIONS WILL BE USED TO CONDUCT RESEARCH, DEVELOPMENT AND IMPLEMENTATION OF TECHNOLOGIES FOR THE EARLY DETECTION AND MONITORING OF TREATMENT INTERVENTIONS FOR BLINDING RETINAL EYE DISEASES, CANCERS AND NEURODEGENERATIVE DISEASES, BY NON-INVASIVE METHODOLIGIES, AS WELL AS MINIMALLY INVASIVE TECHNOLOGIES FOR EARLY CANCER DETECTION AND MONITORING OF EFFECTS OF CHEMOTHERAPY. THE CHARITABLE FUND WILL ALSO MAKE GRANTS TO PARTIALLY FUND CLINICAL TRIALS BY OTHER RESEARCH AND EDUCATIONAL INSTITUTIONS."}],"functional_expense_allocations":{"accounting_fees":{"management_and_general":2420,"total":2420},"occupancy":{"management_and_general":9400,"total":9400},"insurance":{"management_and_general":750,"total":750}},"tax_and_disclosure_flags":{"activities_conducted_through_partnership":false,"foreign_financial_account":false,"backup_withholding_compliance":false,"lobbying_activities":false,"deductible_non_cash_contributions":false,"deductible_contributions_of_art":false,"method_of_accounting_cash":true,"schedule_o_part_vi":true},"principal_officer_detail":{"person_name":"RALPH ZUCKERMAN PHD","address_line1":"325 CHESTNUT STREET","city":"PHILADELPHIA","state":"PA","zip":"19106"},"audit_financial_statement_detail":{"accountant_compile_or_review":false},"related_party_due_diligence":{"officer_entity_with_business_relationship":false,"officer_mailing_address":false,"related_entity":true,"related_org_controlled_entity":true,"compensation_from_other_sources":false,"excess_benefit_transaction":false,"annual_disclosure_covered_persons":false},"grant_due_diligence":{"grants_to_organizations":false,"grants_to_individuals":false,"more_than_5000_to_organizations":false,"more_than_5000_to_individuals":false},"books_are_in_care_of":{"person_name":"ORGANIZATION","phone":"2152381510","address_line1":"325 CHESTNUT STREET SUITE 610","city":"PHILADELPHIA","state":"PA","zip":"19106"},"officers_directors_key_employees":[{"title":"PRESIDENT","average_hours_per_week":5.0,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"officer":true},{"title":"TREAS / SECR","average_hours_per_week":4.0,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"officer":true}]},"ScheduleA":{"public_charity_status":{"publicly_supported_org_170b1_avi":true},"support_170":{"thirty_three_percent_test_current_year":true,"gifts_grants_contributions":{"value":201000,"current_year":50000,"current_year_minus1":20000,"current_year_minus2":130000,"current_year_minus3":1000},"total_calendar_year_support":{"value":201000,"current_year":50000,"current_year_minus1":20000,"current_year_minus2":130000,"current_year_minus3":1000},"public_support_total":201000,"total_support":201000,"public_support_percentage":1.0}},"ScheduleB":{"attached":true,"required":true},"ScheduleR":{"taxable_corporations_and_trusts":[{"ein":232696089,"business_name_line1":"BIOMETRIC IMAGING INC","primary_activity":"RESEARCH","legal_domicile_state":"PA","address_line1":"625 CHESTNUT STREET SUITE 610","city":"PHILADELPHIA","state":"PA","zip":"19106","name":"BIOMETRIC IMAGING INC","address":"625 CHESTNUT STREET SUITE 610, PHILADELPHIA, PA, 19106"}],"transaction_flags":{"gift_grant_or_capital_contribution_from_other_org":false,"gift_grant_or_capital_contribution_to_other_org":false,"loans_or_guarantees_from_other_org":false,"loans_or_guarantees_to_other_org":false,"performance_of_services_by_other_orgs":false,"performance_of_services_for_other_orgs":false,"sharing_of_facilities":false,"sharing_of_paid_employees":false,"reimbursement_paid_by_other_org":false,"reimbursement_paid_to_other_org":false,"rental_of_facilities_from_other_orgs":true,"rental_of_facilities_to_other_orgs":false,"purchase_of_assets_from_other_org":false,"sale_of_assets_to_other_org":false,"exchange_of_assets":false,"receipt_of_interest_annuities_rents_royalties":false,"other_transfer_from_other_org":false,"other_transfer_to_other_org":false},"transactions":[{"business_name_line1":"BIOMETRIC IMAGING INC","amount_involved":10150,"method_of_amount_determination":"ALLOCATION OF ACTUAL COST","transaction_type":"J","name":"BIOMETRIC IMAGING INC"}]},"source_xml":"201102239349301040_public.xml"},{"Organization":{"Hours":[0],"Total Compensation":[0],"Direct compensation":[0],"Other compensation":[0]},"Basic":{"mission":"Conduct research, development and implementation of technologies for the early detection and monitoring of treatment interventions for blinding retinal eye diseases, cancers and neurodegenerative diseases.","primary_activities":"Donations will be used to conduct research, development and implementation of technologies for the early detection and monitoring of treatment interventions for blinding retinal eye diseases, cancers and neurodegenerative diseases, by non-invasive methodoligies, as well as minimally invasive technologies for early cancer detection and monitoring of effects of chemotherapy. The charitable fund will also make grants to partially fund clinical trials by other research and educational institutions.","year":2011,"name":"JULIUS AND SARA ZUCKERMAN","phone":"2152381510","type":"990","principal_officer":"RALPH ZUCKERMAN PHD","year_formation":2007,"state_legal_domicile":"PA","total_volunteers":2,"tax_period_begin":"2011-01-01T00:00:00","tax_period_end":"2011-12-31T00:00:00","address":"325 CHESTNUT STREET SUITE 610, PHILADELPHIA, PA, 19106, USA","city":"PHILADELPHIA","state":"PA","country":"USA","zip_code":"19106"},"Governance":{"501c3 determination":true,"Number of voting members":2,"Number of independent voting members":1,"Number of employees total":0,"Total Gross UBI":0,"Number of employees":0,"Prohibited tax shelter transactions":false,"Taxable party notification":false,"Funds to pay premiums":false,"Premiums Paid":false,"Family or business relationship":false,"Delegation of management duties":false,"Conflict of interest policy":true,"Whistle blower policy":true,"Compensation process for CEO":false,"Compensation process for other employees":false,"Changes to organizing documents":false,"Material diversion or misuse":false,"Members or stockholders":false,"Election of board members":false,"Decisions subject to approval":false,"Minutes of governing body":true,"Local chapters":false,"Form 990 provided to governing body":true,"Document retention policy":true,"Investment in joint venture":false,"Independent audit financial statements":false,"Consolidated audit financial statements":false,"Accountant compile or review":false,"Financial statements audited by independent accountant":false,"Political activities":false,"Donor advised funds":false,"Conservation easements":false,"Collections of art":false,"School":false,"Hospital":false,"Foreign activities":false,"Foreign office":false,"Gaming":false,"Fundraising activities":false,"Professional fundraising":false,"Loan to officer or DQP":false,"Grant to related person":false,"Business relationship through family member":false,"Business relationship with organization":false,"Transfers to exempt non-charitable organization":false},"Revenues":{"value":30000,"Contributions":{"value":30000,"Other contributions":30000},"Program revenue":{"value":0},"Investment income":{"value":0},"Other revenues":{"value":0}},"Expenses":{"value":2410,"Grant expense":{"value":0},"Total professional fundraising expense":{"value":0},"Benefits paid to members":{"value":0},"Salaries":{"value":0},"Other expenses":{"value":2410,"Accounting":2310,"Itemized Expenses":100}},"Assets":{"value":112551,"Non-interest bearing cash":112551},"Liabilities":{"value":0},"Fund balance":{"value":112551},"Form990Details":{"program_service_accomplishments":[{"description":"DONATIONS WILL BE USED TO CONDUCT RESEARCH, DEVELOPMENT AND IMPLEMENTATION OF TECHNOLOGIES FOR THE EARLY DETECTION AND MONITORING OF TREATMENT INTERVENTIONS FOR BLINDING RETINAL EYE DISEASES, CANCERS AND NEURODEGENERATIVE DISEASES, BY NON-INVASIVE METHODOLIGIES, AS WELL AS MINIMALLY INVASIVE TECHNOLOGIES FOR EARLY CANCER DETECTION AND MONITORING OF EFFECTS OF CHEMOTHERAPY. THE CHARITABLE FUND WILL ALSO MAKE GRANTS TO PARTIALLY FUND CLINICAL TRIALS BY OTHER RESEARCH AND EDUCATIONAL INSTITUTIONS."}],"functional_expense_allocations":{"accounting_fees":{"management_and_general":2310,"total":2310}},"tax_and_disclosure_flags":{"activities_conducted_through_partnership":false,"foreign_financial_account":false,"backup_withholding_compliance":false,"lobbying_activities":false,"deductible_non_cash_contributions":false,"deductible_contributions_of_art":false,"method_of_accounting_cash":true,"schedule_o_part_vi":true},"principal_officer_detail":{"person_name":"RALPH ZUCKERMAN PHD","address_line1":"325 CHESTNUT STREET","city":"PHILADELPHIA","state":"PA","zip":"19106"},"audit_financial_statement_detail":{"accountant_compile_or_review":false},"related_party_due_diligence":{"officer_entity_with_business_relationship":false,"officer_mailing_address":false,"related_entity":false,"related_org_controlled_entity":true,"compensation_from_other_sources":false,"excess_benefit_transaction":false,"annual_disclosure_covered_persons":false},"grant_due_diligence":{"grants_to_organizations":false,"grants_to_individuals":false,"more_than_5000_to_organizations":false,"more_than_5000_to_individuals":false},"books_are_in_care_of":{"person_name":"ORGANIZATION","phone":"2152381510","address_line1":"325 CHESTNUT STREET SUITE 610","city":"PHILADELPHIA","state":"PA","zip":"19106"},"officers_directors_key_employees":[{"title":"PRESIDENT","average_hours_per_week":5.0,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"officer":true},{"title":"TREAS / SECR","average_hours_per_week":4.0,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"officer":true}]},"ScheduleA":{"public_charity_status":{"publicly_supported_org_170b1_avi":true},"support_170":{"thirty_three_percent_test_current_year":true,"gifts_grants_contributions":{"value":231000,"current_year":30000,"current_year_minus1":50000,"current_year_minus2":20000,"current_year_minus3":130000,"current_year_minus4":1000},"total_calendar_year_support":{"value":231000,"current_year":30000,"current_year_minus1":50000,"current_year_minus2":20000,"current_year_minus3":130000,"current_year_minus4":1000},"public_support_total":231000,"total_support":231000,"public_support_percentage":1.0}},"ScheduleB":{"attached":true,"required":true},"source_xml":"201231359349305848_public.xml"}],"Latest":{"Organization":{"Hours":[0],"Total Compensation":[0],"Direct compensation":[0],"Other compensation":[0]},"Basic":{"mission":"Conduct research, development and implementation of technologies for the early detection and monitoring of treatment interventions for blinding retinal eye diseases, cancers and neurodegenerative diseases.","primary_activities":"Donations will be used to conduct research, development and implementation of technologies for the early detection and monitoring of treatment interventions for blinding retinal eye diseases, cancers and neurodegenerative diseases, by non-invasive methodoligies, as well as minimally invasive technologies for early cancer detection and monitoring of effects of chemotherapy. The charitable fund will also make grants to partially fund clinical trials by other research and educational institutions.","year":2011,"name":"JULIUS AND SARA ZUCKERMAN","phone":"2152381510","type":"990","principal_officer":"RALPH ZUCKERMAN PHD","year_formation":2007,"state_legal_domicile":"PA","total_volunteers":2,"tax_period_begin":"2011-01-01T00:00:00","tax_period_end":"2011-12-31T00:00:00","address":"325 CHESTNUT STREET SUITE 610, PHILADELPHIA, PA, 19106, USA","city":"PHILADELPHIA","state":"PA","country":"USA","zip_code":"19106"},"Governance":{"501c3 determination":true,"Number of voting members":2,"Number of independent voting members":1,"Number of employees total":0,"Total Gross UBI":0,"Number of employees":0,"Prohibited tax shelter transactions":false,"Taxable party notification":false,"Funds to pay premiums":false,"Premiums Paid":false,"Family or business relationship":false,"Delegation of management duties":false,"Conflict of interest policy":true,"Whistle blower policy":true,"Compensation process for CEO":false,"Compensation process for other employees":false,"Changes to organizing documents":false,"Material diversion or misuse":false,"Members or stockholders":false,"Election of board members":false,"Decisions subject to approval":false,"Minutes of governing body":true,"Local chapters":false,"Form 990 provided to governing body":true,"Document retention policy":true,"Investment in joint venture":false,"Independent audit financial statements":false,"Consolidated audit financial statements":false,"Accountant compile or review":false,"Financial statements audited by independent accountant":false,"Political activities":false,"Donor advised funds":false,"Conservation easements":false,"Collections of art":false,"School":false,"Hospital":false,"Foreign activities":false,"Foreign office":false,"Gaming":false,"Fundraising activities":false,"Professional fundraising":false,"Loan to officer or DQP":false,"Grant to related person":false,"Business relationship through family member":false,"Business relationship with organization":false,"Transfers to exempt non-charitable organization":false},"Revenues":{"value":30000,"Contributions":{"value":30000,"Other contributions":30000},"Program revenue":{"value":0},"Investment income":{"value":0},"Other revenues":{"value":0}},"Expenses":{"value":2410,"Grant expense":{"value":0},"Total professional fundraising expense":{"value":0},"Benefits paid to members":{"value":0},"Salaries":{"value":0},"Other expenses":{"value":2410,"Accounting":2310,"Itemized Expenses":100}},"Assets":{"value":112551,"Non-interest bearing cash":112551},"Liabilities":{"value":0},"Fund balance":{"value":112551},"Form990Details":{"program_service_accomplishments":[{"description":"DONATIONS WILL BE USED TO CONDUCT RESEARCH, DEVELOPMENT AND IMPLEMENTATION OF TECHNOLOGIES FOR THE EARLY DETECTION AND MONITORING OF TREATMENT INTERVENTIONS FOR BLINDING RETINAL EYE DISEASES, CANCERS AND NEURODEGENERATIVE DISEASES, BY NON-INVASIVE METHODOLIGIES, AS WELL AS MINIMALLY INVASIVE TECHNOLOGIES FOR EARLY CANCER DETECTION AND MONITORING OF EFFECTS OF CHEMOTHERAPY. THE CHARITABLE FUND WILL ALSO MAKE GRANTS TO PARTIALLY FUND CLINICAL TRIALS BY OTHER RESEARCH AND EDUCATIONAL INSTITUTIONS."}],"functional_expense_allocations":{"accounting_fees":{"management_and_general":2310,"total":2310}},"tax_and_disclosure_flags":{"activities_conducted_through_partnership":false,"foreign_financial_account":false,"backup_withholding_compliance":false,"lobbying_activities":false,"deductible_non_cash_contributions":false,"deductible_contributions_of_art":false,"method_of_accounting_cash":true,"schedule_o_part_vi":true},"principal_officer_detail":{"person_name":"RALPH ZUCKERMAN PHD","address_line1":"325 CHESTNUT STREET","city":"PHILADELPHIA","state":"PA","zip":"19106"},"audit_financial_statement_detail":{"accountant_compile_or_review":false},"related_party_due_diligence":{"officer_entity_with_business_relationship":false,"officer_mailing_address":false,"related_entity":false,"related_org_controlled_entity":true,"compensation_from_other_sources":false,"excess_benefit_transaction":false,"annual_disclosure_covered_persons":false},"grant_due_diligence":{"grants_to_organizations":false,"grants_to_individuals":false,"more_than_5000_to_organizations":false,"more_than_5000_to_individuals":false},"books_are_in_care_of":{"person_name":"ORGANIZATION","phone":"2152381510","address_line1":"325 CHESTNUT STREET SUITE 610","city":"PHILADELPHIA","state":"PA","zip":"19106"},"officers_directors_key_employees":[{"title":"PRESIDENT","average_hours_per_week":5.0,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"officer":true},{"title":"TREAS / SECR","average_hours_per_week":4.0,"reportable_comp_from_org":0,"reportable_comp_from_related_orgs":0,"other_compensation":0,"officer":true}]},"ScheduleA":{"public_charity_status":{"publicly_supported_org_170b1_avi":true},"support_170":{"thirty_three_percent_test_current_year":true,"gifts_grants_contributions":{"value":231000,"current_year":30000,"current_year_minus1":50000,"current_year_minus2":20000,"current_year_minus3":130000,"current_year_minus4":1000},"total_calendar_year_support":{"value":231000,"current_year":30000,"current_year_minus1":50000,"current_year_minus2":20000,"current_year_minus3":130000,"current_year_minus4":1000},"public_support_total":231000,"total_support":231000,"public_support_percentage":1.0}},"ScheduleB":{"attached":true,"required":true},"Ratings":{"Mission Deployment Rate":{"score":null},"Program Expense Ratio":{"score":null},"Fundraising Efficiency":{"score":null,"percentile":null},"Filing Consistency Score":{"score":1.0},"Grant Itemization Coverage":{"score":null},"Independent Voting Board Pct":{"score":0.5},"Operating Margin":{"score":0.9196666666666666,"percentile":0.986868874929845},"Operating Reserve Ratio":{"score":46.70165975103735,"percentile":0.9779109683849178},"Liabilities to Assets Ratio":{"score":0.0,"percentile":0.8056604925352309},"Officer Compensation Ratio":{"score":null,"percentile":null},"Program Expense Growth":{"score":null,"percentile":null},"Revenue Growth":{"score":null,"percentile":null},"Asset Growth":{"score":null,"percentile":null},"Foreign Oversight Score":{"score":null},"Major-Donor Itemization":{"score":1.0},"Related-Party Transparency":{"score":null},"Pay-Setting Controls":{"score":1.0,"weight":5,"atoms":{"Compensation committee":{"value":true},"Independent compensation consultant":{"value":true},"Form 990 of other organizations reviewed":{"value":true},"Written employment contract":{"value":true},"Compensation survey or study":{"value":true},"Board or committee approval":{"value":true}}},"Governance Policy Score":{"score":0.5555555555555556,"weight":5,"atoms":{"Conflict of interest policy":{"value":true},"Whistle blower policy":{"value":true},"Document retention policy":{"value":true},"Compensation process for CEO":{"value":false},"Compensation process for other employees":{"value":false},"Form 990 provided to governing body":{"value":true},"Minutes of governing body":{"value":true},"Audit committee":{"value":false},"Independent audit financial statements":{"value":false}}},"Categories":{"Financial Efficiency":{"score":null,"weight":45},"Transparency & Controls":{"score":1.0,"weight":20},"Accountability":{"score":0.5231481481481481,"weight":14},"Sustainability":{"score":0.9597217884289206,"weight":13},"Growth":{"score":null,"weight":8}},"Overall Score":{"score":0.8468182409287244,"percentile":0.8275705951759172}},"source_xml":"201231359349305848_public.xml"},"sector":"","donation_categories":[],"zakat_policy":null},"error":null}